Connor Page
patient
Connor Page was a 39-year-old father diagnosed with pancreatic cancer in 2022, whose participation in a clinical trial for the drug daraxonrasib provided him with several months of improved health and valuable time with his family before his passing in 2024.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
31,254
Power
1,398$
Sentiment
6.00
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 6.00 | 0.08% | +0% | 38,005,238 | 31,254 | $1,700,000 | 1,398$ |
| Totals | 1 | 38,005,238 | 31,254 | $1,700,000 | 1,398$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Connor Page learned he had pancreatic cancer in 2022 and participated in a Phase 1 trial.
6
Andre Bourbeau
George Zogopoulos
Jennifer Knox
Mark Johnson
Dana Johnson
Daniel Renouf
Jen Lovrics
Michelle Capobianco
The Globe and Mail: Drug that could extend lives of Canadians with pancreatic cancer remains out of reach for patients